Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women

Noriko Henmi, Kazuhiro Takahashi, Mitsuyoshi Amita, Keiko Takata, Tsuyoshi Ohta, Seiji Tsutsumi, Toshifumi Takahashi, Hirohisa Kurachi
Menopause (New York, N.Y.) · 2010 · vol. 17(3) , pp. 615–621 · doi:10.1097/gme.0b013e3181d273c7 · PMID:20386344 · W2085192851
RCT OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Dienogest did not inhibit estradiol-induced nitric oxide production in endothelial cells or improve endothelium-dependent vasodilatation in postmenopausal women, unlike medroxyprogesterone acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: We investigated the effects of dienogest (DNG), which has a profile similar to that of natural progesterone (P4), on the favorable effects of estrogen in endothelial function. METHODS: (1) Human umbilical vein endothelial cells were treated with medroxyprogesterone acetate (MPA), DNG, or P4 with or without estradiol (E2), and then we examined nitric oxide (NO) production, phosphorylation of Akt, ERK, and endothelial NO synthase. (2) Twenty women with surgical menopause were randomly allocated to four groups: control (no treatment), E2 alone, E2 + MPA, and E2 + DNG. The treatment groups were treated with transdermal E2 (0.72 mg) for 2 days or E2 + MPA (2.5 mg/d) or E2 + DNG (2 mg/d) for a week starting 1 week after the operation; the control group did not use hormone. We examined the changes in the flow-mediated dilatation (FMD) of the brachial artery using ultrasonography. RESULTS: (1) Although MPA attenuated E2-induced NO production and phosphorylation of Akt, extracellular signal-regulated kinase, and endothelial NO synthase, neither DNG nor P4 inhibited E2 effects. (2) A significant decrease in FMD was observed 1 week after the operation in all groups. E2 significantly ameliorated endothelial impairment (FMD, 3.4% +/- 0.9% to 7.6% +/- 1.3%) in the E2-alone group (P < 0.05), but E2 + MPA could not ameliorate endothelial impairment (3.3% +/- 1.1% to 3.5% +/- 1.0%). However, FMD in the E2 + DNG group significantly increased (2.9% +/- 0.5% to 8.7% +/- 1.0%; P < 0.05). CONCLUSIONS: These results suggest that DNG did not inhibit the restoration of vasodilatation by E2. DNG may have an advantage compared with MPA on the endothelial function in postmenopausal women receiving hormone therapy.

My notes (saved in your browser only)

MeSH descriptors

Brachial Artery Endothelial Cells Nandrolone Nitric Oxide Umbilical Veins Vasodilation Blood Flow Velocity Blood Flow Velocity Brachial Artery Brachial Artery Dose-Response Relationship, Drug Endothelial Cells Endothelial Cells Endothelium, Vascular Endothelium, Vascular Endothelium, Vascular Estradiol Estradiol Female Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (34)

Cited by (1)

SciLite annotations

chemicals 10
dienogest estrogen nitric oxide dienogest progesterone estrogen medroxyprogesterone acetate estradiol nitric oxide
organisms 3
human noordeloos 2009062 human

Source provenance

openalex
last seen: 2026-05-11T06:20:36.346967+00:00
pubmed
last seen: 2026-10-08T21:07:31.877465+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK